US-based contract research organisation (CRO) Quintiles Transnational says the central laboratory it opened early last year in Mumbai, India has now been certified by the College of American Pathologists (CAP).

This gives Quintiles “the largest wholly owned CAP-accredited laboratory network in the world”, it claimed. With CAP-certified laboratories in the US, Europe, South Africa, China, India and Singapore, as well as “tightly controlled” sub-contractor laboratories in Argentina and Brazil managed by Quintiles employees on-site, the CRO can support global and regional clinical trials in “almost every country in the world”, meeting client demand for “the quality, flexibility and speed that come from running multi-regional global trials”, it added.

CAP certification, which follows a site inspection, aims to improve patient safety by advancing the quality of pathology and laboratory services through education, standard-setting and ensuring laboratories meet or exceed regulatory requirements.

The Mumbai laboratory consolidated Quintiles’ long-standing presence in the Indian market, where it had first set up an office in Ahmedabad 10 years previously, subsequently adding offices in Mumbai and Bangalore while expanding its clinical research staff in India to around 750.

The new central laboratory began supporting clinical trials in the first quarter of 2007. Since then, the facility has experienced steady growth and has been adding services and analytical capabilities to a growing test menu, Quintiles said.

In addition to laboratory testing, the Mumbai facility provides project management and logistical support, study-specific laboratory kits for trial sites, local investigator support and sample management, storage and processing. All of the laboratory data collected are globally harmonised and incorporated in the Quintiles Laboratory Information Management System (QLIMS) and the protocol-specific database, the CRO noted.